Chris Raymond
Analyst
Analyst — Raymond James
Earnings-call appearances
-
Sionna Therapeutics, Inc. Q2 FY2026 Earnings Call2026-08-06
Sionna Therapeutics, Inc. (SION)
-
BioMarin Pharmaceutical Second Quarter 2026 Conference Call2026-08-06
Biomarin Pharmaceutical Inc (BMRN)
-
TSHA-102 Rett Syndrome Program Update Conference Call2026-06-22
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q1 FY2026 Earnings Call2026-05-06
Taysha Gene Therapies, Inc. (TSHA)
-
Biomarin Pharmaceutical Inc Q1 FY2026 Earnings Call2026-05-04
Biomarin Pharmaceutical Inc (BMRN)
-
Taysha Gene Therapies, Inc. Q4 FY2025 Earnings Call2026-03-19
Taysha Gene Therapies, Inc. (TSHA)
-
Biomarin Pharmaceutical Inc Q4 FY2025 Earnings Call2026-02-23
Biomarin Pharmaceutical Inc (BMRN)
-
Regeneron Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-01-30
Regeneron Pharmaceuticals, Inc. (REGN)
-
Taysha Gene Therapies, Inc. Q3 FY2025 Earnings Call2025-11-04
Taysha Gene Therapies, Inc. (TSHA)
-
Biomarin Pharmaceutical Inc Q3 FY2025 Earnings Call2025-10-27
Biomarin Pharmaceutical Inc (BMRN)